Hyundai Bioscience Co., Ltd. (048410.KQ) KOE

5,600.00

-270(-4.60%)

Updated at December 05 12:13PM

Currency In KRW

Valuation

Market Cap561.83B
Enterprise Value584.77B
P/E Ratio-25
PEG Ratio0.53
Price/Sales Ratio294.4
Price/Book Ratio4.39
Enterprise/Revenue290
Enterprise/EBITDA-52.37

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-10.77
Operating Margin-8.16

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.26

Income Statement

Revenue15.05B
Revenue/Share21.24
Gross Profit11.87B
EBITDA-3.98B
Net Income-6.93B
Diluted EPS-87.02

Balance Sheet

Total Cash35.56B
Total Cash/Share404.8
Total Debt3.37B
Total Debt/Equity0.03
Current Ratio8.38
Book Value Per Share1,303.02

Price History

52-Week Change-13.79
52-Week High8,225
52-Week Low4,325
Moving Average 50 Days5,268.6
Moving Average 200 Days5,573.6

Statistics

Average Volume558,601
Shares Outstanding96.04M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:1
Last Split DateJuly 24, 2025